Greenwich LifeSciences, Inc. (GLSI) — research page
US · us-cm-kg/NASDAQ/GLSI · as of 2026-11-08
Identity and listing
Greenwich LifeSciences, Inc. is listed on NASDAQ under the ticker GLSI, with ISIN US3968791083. The record holds no LEI for the issuer, as no GLEIF record matches the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Greenwich LifeSciences, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | GLSI | source · 2026-11-08 |
| ISIN | US3968791083 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 20 filings across 18 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 3 AGM/EGM, 11 directors' dealings, 2 regulatory filings and 4 results. The median gap between filing days is 9 days, and the latest filing is 13 days before the record date. The latest filing is an AGM/EGM dated 2026-10-26. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days. On the sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 20 | 9 | 13 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-26 | agm_egm | DEFA14A | DEFA14A — DEFA14A |
| 2026-10-26 | regulatory_filing | ARS | ARS — ARS |
| 2026-10-26 | agm_egm | DEF 14A | DEF 14A — DEF 14A |
| 2026-08-11 | results | 10-Q | 10-Q — 10-Q |
| 2026-07-30 | directors_dealings | 4 | 4 — 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is MaloneBailey, LLP, located in Houston, Texas. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read, and the count is 0.
Open research
The record holds 1 openly published research note, by Noble Capital Markets, dated 2025-08-20.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-08-20 | Noble Capital Markets | Greenwich LifeSciences, Inc. Initiating Coverage With An Outperform Rating and $45 Price Target | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001799788.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/GLSI (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1799788/000149315226026651/form10-k.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://greenwichlifesciences.com/wp-content/uploads/2025/08/GLSI_20250820_27715.pdf (open research)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/GLSI (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US3968791083"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:81d7c5976d9ccc3e.